Blog - Health Business Group

Everyone’s worried about new drug tariffs—but they’re actually boosting U.S. Contract Development and Manufacturing Organizations (CDMOs). With tariffs driving up the cost of China-sourced APIs and packaging, American CDMOs with local supply chains are suddenly faster, higher quality, and even cheaper. For private equity investors, these “tariff-resistant” networks are a soli...

As tariffs rise and the government pushes for more domestic production, new opportunities for private equity investment are opening up in the U.S. CDMO market. In this short, David Williams breaks down the three hottest areas for private equity investment: sterile injectables, continuous manufacturing, and quality-driven roll-ups.

Learn how to identify the next big val...

Mass General Brigham is working with K Health to provide AI pre-visits to patients who lack primary care. They should extend it to everyone.

Qualtrics’ acquisition of Press Ganey isn’t just another data or survey deal, it’s a pivotal moment for AI in healthcare.

Press Ganey’s tools are embedded deep in hospital operations and tied to metrics that drive quality, value-based payments, and staff performance. Combine that with Qualtrics’ analytics and experience management platform, and you get a system that ca...